Hyderabad Telangana, India

Babu Ireni

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Hyderabad, IN (2006 - 2015)
  • Nizamabad, IN (2012 - 2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Babu Ireni: Innovator in Pharmaceutical Chemistry

Introduction

Babu Ireni is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development and preparation of important pharmaceutical compounds.

Latest Patents

Babu Ireni's latest patents include innovative processes for the preparation of fingolimod and its salts. The present application provides processes for the preparation of fingolimod and its pharmaceutically acceptable salts, as well as processes for the purification of fingolimod hydrochloride and the preparation of amorphous fingolimod hydrochloride. Additionally, he has developed processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof. This involves a process for the preparation of sitagliptin of Formula II or a pharmaceutically acceptable salt thereof by deprotection of Formula IX.

Career Highlights

Babu Ireni is currently associated with Dr. Reddy's Laboratories, Incorporated, a leading pharmaceutical company known for its innovative drug development. His work at the company has been instrumental in advancing pharmaceutical formulations and improving therapeutic options.

Collaborations

Some of his notable coworkers include Pratap Reddy Padi and Srinivas Polavarapu, who have collaborated with him on various projects within the pharmaceutical domain.

Conclusion

Babu Ireni's contributions to pharmaceutical chemistry through his patents and work at Dr. Reddy's Laboratories highlight his role as an innovator in the industry. His dedication to developing new pharmaceutical processes continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…